Wednesday, 5 August 2020

VAXART top COVID VACCINE STOCK after NOVAVAX presents Phase I results




A wild day with COVID VACCINE STOCKS, after Novavax presents some good news in a Phase I trial. Stat news messed up its news story initially, resulting in a temporary deep dive in after hours. The stock closed at $169.90, up 8.1% after today's trading. Perhaps as a result of Novavax's progress, Moderna dropped 4.2%. 

The winning stock today was Vaxart, up 10.4%. Other strong performers were Emergent (which has arrangements with Novavax for production and distribution of the vaccine) was up 8.2%. Inovio was up 7%, for its best day in some time.

Today's loser was GeoVax, down almost 11%. PDS Bio dropped 6.4%. 

Overall, it was a relatively flat day with 14 stocks down and 13 up. The average COVID VACCINE STOCK was up 0.7%.

Tuesday, 4 August 2020

Sorrento Therapeutics adds one third in value. Slight gain overall -- up 1.2% on average



Sorrento Therapeutics had a great day - up over 31%. 

The rest of the COVID VACCINE STOCKS were relatively flat with an average gain of 1.2%. Sixteen were up with eleven down.

PDS Bio was up over 8.5% and GeoVax was up 5.5%. Emergent had another strong day - up almost 4%. Altimmune had another good day, gaining over 3%. 

On the down side, Atara Bio and NantKwest fell over 8%.

Novavax release of Phase I info causes firestorm in after hours trading: 

Monday, 3 August 2020

COVID VACCINE STOCKS take off! PDS #1


 

Happy days are here again! COVID VACCINE STOCKS take off with a vengeance.

It has been exactly two weeks since these stocks registering such a blow out day. These companies were up just under 5% on average.

Fully 22 of the 27 stocks were up - some way up.

PDS Biotechnology rocketed up the most, adding 17.5% to lead the way. GeoVax was next, up almost 14%. Both Biondvax and Dynavax were up over 10%. There were many companies up in the high single digits - including many of the big names like Moderna and NVAX.





This week's bottom COVID VACCINE STOCKS - DVAX out, TBIO in -- Emergent Bio moving up





Quite stable bottom 10 COVID VACCINE STOCKS with only DVAX climbing out and replaced by Translate Bio whose return fell from 138% to 100% since March 1. 

Generex Bio remains at the bottom with a loss of 55% since March 1. Its numbers are poor based on the March 1 selected date as it had just popped up to $1.41 and then went straight back down. 

Emergent Bio had the best week of the group with a strong close on Friday--going from a 62% return to 101%. The only other one of these stocks with a positive week was Adaptive Bio which went from a 29% to a 33% return.

Saturday, 1 August 2020

Novavax gains on pack -- 798% return since March 1





Novavax still number one of all COVID VACCINE STOCKS with an amazing 794% return since March 1. 

The Top Ten are the same stocks again this week some minor re-shuffling. Sorrento has gone from 10th to 6th and Altimmune has gone from third to second.

Returns for the 27 COVID VACCINE STOCKS dropped to 198% in total, down from 215% last week. Novavax remains the leader of this group, gaining again this week from a return of 737% last week to 794% this week.

All but 2 of these stocks have a positive return since March 1.